Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates
- 1 November 1994
- Vol. 37 (11-12) , 411-416
- https://doi.org/10.1111/j.1439-0507.1994.tb00391.x
Abstract
Summary. The drug concentration which inhibited 50% of growth (IC30), the lowest drug concentration at which growth was less than 30% of that in a positive control well (IC30), the visual minimal inhibitory concentration (MIC visual), were applied to study the effects of fluconazole, itraconazole, amphotericin B and flucytosine against 27 isolates of Cryptococcus neoformans by a broth microdilution technique. When the recommendations established by NCCLS Subcommittee on Antifungal Susceptibility Tests were applied for the visual reading of the microplates, the results were comparable with those obtained by the turbidimetric method. No statistically significant differences between MIC visual and IC30 readings were observed with the azoles. There were, however, differences with amphotericin B and flucytosine. In absolute terms MICs of amphotericin B and flucytosine showed higher values than IC30S and IC50S.Zusammenfassung. Die turbidimetrisch bestimmte 50%‐Hemmkonzentration (IC50), die 30%‐Hemmkonzentration (IC30) und die visuell bestimmte minimale Hemmkonzentration (MIC visual) wurden vergleichend eingesetzt, um die Wirkung von Fluconazol, Itraconazol, Amphotericin B und Flucytosin auf 27 klinische Isolate von Cryptococcus neoformans zu untersuchen. Bei Berück‐sichtigung der Empfehlungen des NCCLS Subcommitee of Antifungal Susceptibility Tests für die visuelle Ablesung der Mikrotiterplatten sind die Ergebnisse mit denen des turbidometrischen Verfahres vergleichbar. Für die Ablesungen im MIC visual‐ und IC30‐Test wurden bei den Azolen keine signifikanten Unterschiede gefunden. Signifikante Unterschiede gab es dagegen für Amphotericin B und Flucytosin. Absolut gesehen waren die MICs von Amphotericin B und Flucytosin höher als die IC30‐ und IC50‐Werte.Keywords
This publication has 16 references indexed in Scilit:
- Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeastsAntimicrobial Agents and Chemotherapy, 1993
- Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDSAntimicrobial Agents and Chemotherapy, 1992
- Collaborative investigation of variables in susceptibility testing of yeastsAntimicrobial Agents and Chemotherapy, 1990
- Maintenance Amphotericin B for Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988
- Oral Fluconazole as Suppressive Therapy of Disseminated Cryptococcosis in Patients with Acquired Immunodeficiency SyndromeThe American Journal of Medicine, 1988
- Cryptococcal Meningitis in Patients with AIDSThe Journal of Infectious Diseases, 1988
- In Vitro Antifungal Susceptibility Testing and Measurement of Levels of Antifungal Agents in Body FluidsClinical Infectious Diseases, 1987
- Cryptococcal Disease in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Cryptococcosis in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum SizeAntimicrobial Agents and Chemotherapy, 1976